Vassilis Georgoulias

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kioulafa Magdalini; Balkouranidou Ioanna; Sotiropoulou Georgia; Kaklamanis Loukas; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
Saridaki Zacharenia; Pappas Periklis; Souglakos John; Nikolaidou Martha; Vardakis Nikolaos; Kotsakis Athanasios; Marselos Marios; Georgoulias Vassilis; Mavroudis Dimitris
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.
Apostolaki Stella; Perraki Maria; Kallergi Galatea; Kafousi Maria; Papadopoulos Savvas; Kotsakis Athanasios; Pallis Athanasios; Xenidis Nikolaos; Kalmanti Lyda; Kalbakis Kostas; Agelaki Sofia; Kalykaki Antonia; Stournaras Christos; Stathopoulos Efstathios; Georgoulias Vassilis; Mavroudis Dimitris
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Vassilis Georgoulias (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kioulafa Magdalini; Balkouranidou Ioanna; Sotiropoulou Georgia; Kaklamanis Loukas; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Methylation of cystatin M promoter is associated with unfavorable prognosis in operable breast cancer.
International journal of cancer. Journal international du cancer 2009;125(12):2887-92.
2009: Saridaki Zacharenia; Pappas Periklis; Souglakos John; Nikolaidou Martha; Vardakis Nikolaos; Kotsakis Athanasios; Marselos Marios; Georgoulias Vassilis; Mavroudis Dimitris
A dose escalation and pharmacokinetic study of the biweekly administration of paclitaxel, gemcitabine and oxaliplatin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2009;65(1):121-8.
2009: Apostolaki Stella; Perraki Maria; Kallergi Galatea; Kafousi Maria; Papadopoulos Savvas; Kotsakis Athanasios; Pallis Athanasios; Xenidis Nikolaos; Kalmanti Lyda; Kalbakis Kostas; Agelaki Sofia; Kalykaki Antonia; Stournaras Christos; Stathopoulos Efstathios; Georgoulias Vassilis; Mavroudis Dimitris
Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance.
Breast cancer research and treatment 2009;117(3):525-34.
2009: Bozionelou Vasiliki; Kalbakis Kostas; Vamvakas Lambros; Agelaki Sofia; Androulakis Nikolaos; Kalykaki Antonia; Georgoulias Vassilis; Mavroudis Dimitris
A phase I trial of gemcitabine, docetaxel and carboplatin administered every 2 weeks as first line treatment in patients with advanced breast cancer.
Cancer chemotherapy and pharmacology 2009;64(4):785-91.
2009: Daskalaki A; Agelaki S; Perraki M; Apostolaki S; Xenidis N; Stathopoulos E; Kontopodis E; Hatzidaki D; Mavroudis D; Georgoulias V
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer.
British journal of cancer 2009;101(4):589-97.
2009: Souglakos J; Philips J; Wang R; Marwah S; Silver M; Tzardi M; Silver J; Ogino S; Hooshmand S; Kwak E; Freed E; Meyerhardt J A; Saridaki Z; Georgoulias V; Finkelstein D; Fuchs C S; Kulke M H; Shivdasani R A
Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.
British journal of cancer 2009;101(3):465-72.
2009: Agelaki Sophia; Spiliotaki Maria; Markomanolaki Harris; Kallergi Galatea; Mavroudis Dimitris; Georgoulias Vassilis; Stournaras Christos
Caveolin-1 regulates EGFR signaling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition.
Cancer biology & therapy 2009;8(15):1470-7.
2009: Pallis Athanasios G; Agelidou Athina; Agelaki Sofia; Varthalitis Ioannis; Pavlakou Georgia; Gerogianni Aleka; Papakotoulas Pavlos; Rapti Ageliki; Chandrinos Vassilis; Christophyllakis Charalampos; Georgoulias Vassilis
A multicenter randomized phase II study of the irinotecan/gemcitabine doublet versus irinotecan monotherapy in previously treated patients with extensive stage small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2009;65(2):187-91.
2009: Kioulafa Magdalini; Kaklamanis Loukas; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Prognostic significance of RASSF1A promoter methylation in operable breast cancer.
Clinical biochemistry 2009;42(10-11):970-5.
2009: Papadaki Chara; Mavroudis Dimitris; Trypaki Maria; Koutsopoulos Anastasios; Stathopoulos Efstathios; Hatzidaki Dora; Tsakalaki Eleftheria; Georgoulias Vassilis; Souglakos John
Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3827-33.
2009: Kioulafa M; Kaklamanis L; Stathopoulos E; Mavroudis D; Georgoulias V; Lianidou E S
Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(6):1020-5.
2009: Vamvakas Lambros; Saloustros Emmanouel; Karampeazis Athanasios; Georgoulias Vassilis
Advanced non-small-cell lung cancer in the elderly.
Clinical lung cancer 2009;10(3):158-67.
2009: Xenidis Nikolaos; Ignatiadis Michail; Apostolaki Stella; Perraki Maria; Kalbakis Kostas; Agelaki Sofia; Stathopoulos Efstathios N; Chlouverakis Grigorios; Lianidou Evi; Kakolyris Stylianos; Georgoulias Vassilis; Mavroudis Dimitris
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2177-84.
2009: Di Maio Massimo; Chiodini Paolo; Georgoulias Vassilis; Hatzidaki Dora; Takeda Koji; Wachters Floris M; Gebbia Vittorio; Smit Egbert F; Morabito Alessandro; Gallo Ciro; Perrone Francesco; Gridelli Cesare
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(11):1836-43.
2009: Kalikaki Aristea; Kanaki Maria; Vassalou Helen; Souglakos John; Voutsina Alexandra; Georgoulias Vassilis; Mavroudis Dimitris
DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.
Clinical lung cancer 2009;10(2):118-23.
2009: Kouroussis Charalambos; Vamvakas Lambros; Vardakis Nikolaos; Kotsakis Athanasios; Kalykaki Antonia; Kalbakis Kostas; Saridaki Zacharenia; Kentepozidis Nikolaos; Giassas Stelios; Georgoulias Vassilis
Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study.
Oncology 2009;76(2):112-7.
2008: Ignatiadis Michail; Georgoulias Vassilis; Mavroudis Dimitris
Micrometastatic disease in breast cancer: clinical implications.
European journal of cancer (Oxford, England : 1990) 2008;44(18):2726-36.
2008: Saloustros Emmanouel; Mavroudis Dimitris; Georgoulias Vassilis
Paclitaxel and docetaxel in the treatment of breast cancer.
Expert opinion on pharmacotherapy 2008;9(15):2603-16.
2008: Markou Athina; Tsaroucha Emily G; Kaklamanis Loukas; Fotinou Marianthi; Georgoulias Vassilis; Lianidou Evi S
Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.
Clinical chemistry 2008;54(10):1696-704.
2008: Kalikaki A; Koutsopoulos A; Trypaki M; Souglakos J; Stathopoulos E; Georgoulias V; Mavroudis D; Voutsina A
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
British journal of cancer 2008;99(6):923-9.
2008: Gioulbasanis Ioannis; Saridaki Zacharenia; Kalykaki Antonia; Vamvakas Lambros; Kalbakis Kostas; Ignatiadis Michail; Amarantidis Kyriakos; Kakolyris Stylianos; Georgoulias Vassilis; Mavroudis Dimitris
Gefitinib in combination with gemcitabine and vinorelbine in patients with metastatic breast cancer pre-treated with taxane and anthracycline chemotherapy: a phase I/II trial.
Anticancer research 2008;28(5B):3019-25.
2008: Saloustros Emmanouel; Georgoulias Vassilis
Docetaxel in the treatment of advanced non-small-cell lung cancer.
Expert review of anticancer therapy 2008;8(8):1207-22.
2008: Kalbakis Kostas; Pappas Periklis; Kouroussis Charalambos; Vamvakas Lambros; Kalykaki Antonia; Vardakis Nikolaos; Nikolaidou Martha; Marselos Marios; Georgoulias Vassilis; Mavroudis Dimitris
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and oxaliplatin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2008;62(3):449-56.
2008: Ignatiadis Michail; Kallergi Galatea; Ntoulia Maria; Perraki Maria; Apostolaki Stella; Kafousi Maria; Chlouverakis Grigorios; Stathopoulos Efstathios; Lianidou Evi; Georgoulias Vassilis; Mavroudis Dimitris
Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2593-600.
2008: Pallis Athanasios G; Polyzos Aris; Boukovinas Ioannis; Agelidou Athina; Lamvakas Lambros; Tsiafaki Xanthi; Agelidou Maria; Pavlakou Georgia; Chandrinos Vassilis; Kakolyris Stelios; Christophyllakis Charalambos; Kentepozidis Nikolaos; Giassas Stelios; Androulakis Nikolaos; Agelaki Sophia; Georgoulias Vassilis
Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/gemcitabine regimen: the Hellenic Oncology Research Group experience.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):505-10.
2008: Souglakos J; Boukovinas I; Taron M; Mendez P; Mavroudis D; Tripaki M; Hatzidaki D; Koutsopoulos A; Stathopoulos E; Georgoulias V; Rosell R
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine.
British journal of cancer 2008;98(10):1710-5.
2008: Stathopoulos George P; Androulakis Nikos; Souglakos John; Stathopoulos John; Georgoulias Vassilis
Present treatment and future expectations in advanced pancreatic cancer.
Anticancer research 2008;28(2B):1303-8.
2008: Ignatiadis Michail; Georgoulias Vassilis; Mavroudis Dimitris
Circulating tumor cells in breast cancer.
Current opinion in obstetrics & gynecology 2008;20(1):55-60.
2008: Kalykaki Antonia; Papakotoulas Pavlos; Tsousis Sofoklis; Boukovinas Ioannis; Kalbakis Kostas; Vamvakas Lambros; Kotsakis Athanasios; Vardakis Nikolaos; Papadopoulou Persefoni; Georgoulias Vassilis; Mavroudis Dimitris;
Gemcitabine plus oxaliplatin (GEMOX) in pretreated patients with advanced ovarian cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
Anticancer research 2008;28(1B):495-500.
2008: Georgoulias Vassilis; Androulakis Nikolaos; Kotsakis Athanasios; Hatzidaki Dora; Syrigos Kostas; Polyzos Aris; Agelidou Athina; Varthalitis Ioannis; Ziras Nikoalos; Agelidou Maria; Chandrinos Vassilis; Boukovinas Ioannis; Geroyianni Alexandra; Vamvakas Lambros; Mavroudis Dimitris
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
Lung cancer (Amsterdam, Netherlands) 2008;59(1):57-63.
2008: Boukovinas Ioannis; Papadaki Chara; Mendez Pedro; Taron Miquel; Mavroudis Dimitris; Koutsopoulos Anastasios; Sanchez-Ronco Maria; Sanchez Jose Javier; Trypaki Maria; Staphopoulos Eustathios; Georgoulias Vassilis; Rosell Rafael; Souglakos John
Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients.
PloS one 2008;3(11):e3695.
2008: Kallergi Galatea; Agelaki Sofia; Kalykaki Antonia; Stournaras Christos; Mavroudis Dimitris; Georgoulias Vassilis
Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients.
Breast cancer research : BCR 2008;10(5):R80.
2008: Kakolyris S; Souglakos J; Polyzos A; Ardavanis A; Ziras N; Athanasiadis A; Varthalitis I; Amarantidis K; Tsousis S; Vamvakas L; Vardakis N; Georgoulias V;
Modified CAPOX (capecitabine plus oxaliplatin) regimen every two weeks as second-line treatment in patients with advanced colorectal cancer previously treated with irinotecan-based frontline therapy: a multicenter phase II study.
Oncology 2008;74(1-2):31-6.
2007: Ignatiadis Michail; Perraki Maria; Apostolaki Stella; Politaki Eleni; Xenidis Nikos; Kafousi Maria; Stathopoulos Efstathios; Lianidou Evi; Sotiriou Christos; Georgoulias Vassilis; Mavroudis Dimitris
Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
Clinical breast cancer 2007;7(11):883-9.
2007: Pallis A G; Voutsina A; Kalikaki Ar; Souglakos J; Briasoulis E; Murray S; Koutsopoulos A; Tripaki M; Stathopoulos E; Mavroudis D; Georgoulias V
'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer.
British journal of cancer 2007;97(11):1560-6.
2007: Ignatiadis Michail; Xenidis Nikos; Perraki Maria; Apostolaki Stella; Politaki Eleni; Kafousi Maria; Stathopoulos Efstathios N; Stathopoulou Aliki; Lianidou Evi; Chlouverakis Grigorios; Sotiriou Christos; Georgoulias Vassilis; Mavroudis Dimitris
Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(33):5194-202.
2007: Maniadakis N; Fragoulakis V; Pallis A; Prezerakos P; Georgoulias V
Economic evaluation of docetaxel/gemcitabine versus docetaxel as frontline treatment of patients with advanced/metastatic non-small cell lung cancer in Greece.
Lung cancer (Amsterdam, Netherlands) 2007;58(2):275-81.
2007: Douillard Jean-Yves; Laporte Silvy; Fossella Frank; Georgoulias Vassilis; Pujol Jean-Louis; Kubota Kaoru; Monnier Alain; Kudoh Shinzoh; Rubio Jaime Ernesto; Cucherat Michel
Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(10):939-46.
2007: Xenidis N; Markos V; Apostolaki S; Perraki M; Pallis A; Sfakiotaki G; Papadatos-Pastos D; Kalmanti L; Kafousi M; Stathopoulos E; Kakolyris S; Mavroudis D; Georgoulias V
Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1623-31.
2007: Nordlinger Bernard; Van Cutsem Eric; Rougier Philippe; Köhne Claus-Henning; Ychou Marc; Sobrero Alberto; Adam Rene; Arvidsson Dag; Carrato Alfredo; Georgoulias Vassilis; Giuliante Felice; Glimelius Bengt; Golling Markus; Gruenberger Thomas; Tabernero Josep; Wasan Harpreet; Poston Graeme;
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group.
European journal of cancer (Oxford, England : 1990) 2007;43(14):2037-45.
2007: Maniadakis N; Pallis A; Fragoulakis V; Prezerakos P; Georgoulias V
Economic analysis of a multicentre, randomised, phase III trial comparing FOLFOXIRI with FOLFIRI in patients with metastatic colorectal cancer in Greece.
Current medical research and opinion 2007;23(9):2251-7.
2007: Koutsopoulos Anastassios V; Mavroudis Dimitris; Dambaki Konstantina I; Souglakos John; Tzortzaki Eleni G; Drositis John; Delides George S; Georgoulias Vassilis; Stathopoulos Efstathios N
Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
Lung cancer (Amsterdam, Netherlands) 2007;57(2):193-200.
2007: Bolonaki Irini; Kotsakis Athanassios; Papadimitraki Elsa; Aggouraki Despoina; Konsolakis George; Vagia Aphrodite; Christophylakis Charalambos; Nikoloudi Irini; Magganas Elefterios; Galanis Athanassios; Cordopatis Paul; Kosmatopoulos Kostas; Georgoulias Vassilis; Mavroudis Dimitris
Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2727-34.
2007: Bozionelou V; Vamvakas L; Pappas P; Agelaki S; Androulakis N; Kalykaki A; Nikolaidou M; Kentepozidis N; Giassas S; Marselos M; Georgoulias V; Mavroudis D
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours.
British journal of cancer 2007;97(1):43-9.
2007: Apostolaki S; Perraki M; Pallis A; Bozionelou V; Agelaki S; Kanellou P; Kotsakis A; Politaki E; Kalbakis K; Kalykaki A; Vamvakas L; Georgoulias V; Mavroudis D
Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):851-8.
2007: Gkioulbasanis I; Souglakos J; Vardakis N; Kotsakis A; Saridaki Z; Kentepozidis N; Polyzos A; Giassas S; Ignatiadis M; Bozionelou V; Christophylakis C; Georgoulias V
Dose escalating clinical study of high dose infusional 5-fluorouracil and leukovorin (AIO regimen) plus alternate weekly administration of oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal tract.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2007;12(2):197-202.
2007: Michalakis John; Georgatos Spyros D; de Bree Eelco; Polioudaki Hara; Romanos John; Georgoulias Vassilis; Tsiftsis Dimitris D; Theodoropoulos Panayiotis A
Short-term exposure of cancer cells to micromolar doses of paclitaxel, with or without hyperthermia, induces long-term inhibition of cell proliferation and cell death in vitro.
Annals of surgical oncology 2007;14(3):1220-8.
2007: Souglakos J; Kalykaki A; Vamvakas L; Androulakis N; Kalbakis K; Agelaki S; Vardakis N; Tzardi M; Kotsakis A P; Gioulbasanis J; Tsetis D; Sfakiotaki G; Chatzidaki D; Mavroudis D; Georgoulias V
Phase II trial of capecitabine and oxaliplatin (CAPOX) plus cetuximab in patients with metastatic colorectal cancer who progressed after oxaliplatin-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(2):305-10.
2007: Kallergi Galatea; Mavroudis Dimitris; Georgoulias Vassilis; Stournaras Christos
Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells.
Molecular medicine (Cambridge, Mass.) 2007;13(1-2):79-88.
2007: Pallis A G; Christofillakis Ch; Tselepatiotis E; Agelaki S; Vamvakas L; Souglakos J; Vardakis N; Kalykaki A; Kotsakis A; Argiraki A; Mavroudis D; Georgoulias V
Sequential administration of docetaxel followed by maintenance gefitinib, as salvage treatment in patients with advanced NSCLC: a multicenter phase II trial.
Lung cancer (Amsterdam, Netherlands) 2007;55(1):101-7.
2007: Saridaki Zacharenia; Bozionelou Vasiliki; Kentepozidis Nikolaos; Kotsakis Athanasios; Vardakis Nikolaos; Kalykaki Antonia; Gioulbasanis Ioannis; Karampeazis Athanasios; Vamvakas Lambros; Georgoulias Vassilis; Mavroudis Dimitris
A dose escalation study of the biweekly administration of paclitaxel, oxaliplatin and capecitabine in patients with advanced solid tumors.
Oncology 2007;72(1-2):45-50.
2007: Kallergi Galatea; Agelaki Sofia; Markomanolaki Harris; Georgoulias Vassilis; Stournaras Christos
Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells.
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2007;20(6):977-86.
2007: Emmanouilides Christos; Sfakiotaki Georgia; Androulakis Nikolaos; Kalbakis Kostas; Christophylakis Charalambos; Kalykaki Antonia; Vamvakas Lambros; Kotsakis Athanasios; Agelaki Sofia; Diamandidou Eleni; Touroutoglou Nikolaos; Chatzidakis Adam; Georgoulias Vassilis; Mavroudis Dimitris; Souglakos John
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study.
BMC cancer 2007;7():91.
2007: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
Digestive diseases (Basel, Switzerland) 2007;25(1):100-5.
2006: Kakolyris Stylianos; Ziras Nikolaos; Vamvakas Lambros; Varthalitis John; Papakotoulas Pavlos; Syrigos Kostas; Vardakis Nikolaos; Kalykaki Antonia; Amarantidis Kiriakos; Georgoulias Vassilis
Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): a multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2006;54(3):347-52.
2006: Ardavanis Alexandros; Mavroudis Dimitris; Kalbakis Kostas; Malamos Nikolaos; Syrigos Kostas; Vamvakas Lambros; Kotsakis Athanasios; Kentepozidis Nikolaos; Kouroussis Charalambos; Agelaki Sophia; Georgoulias Vassilis;
Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study.
Cancer chemotherapy and pharmacology 2006;58(6):742-8.
2006: Pappas Periklis; Mavroudis Dimitris; Nikolaidou Martha; Georgoulias Vassilis; Marselos Marios
Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine.
Anti-cancer drugs 2006;17(10):1185-91.
2006: Boukovinas I; Androulakis N; Vamvakas L; Papakotoulas P; Ziras N; Polyzos A; Kalykaki A; Kotsakis A; Xenidis N; Gioulmbasanis I; Mavroudis D; Georgoulias V
Sequential gemcitabine and cisplatin followed by docetaxel as first-line treatment of advanced urothelial carcinoma: a multicenter phase II study of the Hellenic Oncology Research Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(11):1687-92.
2006: Chan A; Martin M; Untch M; Gil M G; Guillem-Porta V; Wojtukiewicz M; Kellokumpu-Lehtinen P; Sommer H L; Georgoulias V; Battelli N; Pawlicki M; Aubert D; Bourlard T; Gasmi J; Villanova G; Petruzelka L;
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.
British journal of cancer 2006;95(7):788-93.
2006: Koukouraki Sophia; Strauss Ludwig G; Georgoulias Vassilios; Eisenhut Michael; Haberkorn Uwe; Dimitrakopoulou-Strauss Antonia
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
European journal of nuclear medicine and molecular imaging 2006;33(10):1115-22.
2006: Stathopoulou Aliki; Ntoulia Maria; Perraki Maria; Apostolaki Stella; Mavroudis Dimitris; Malamos Nikos; Georgoulias Vassilis; Lianidou Evi S
A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer.
International journal of cancer. Journal international du cancer 2006;119(7):1654-9.
2006: Ntoulia Maria; Stathopoulou Aliki; Ignatiadis Michail; Malamos Nikos; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
Clinical biochemistry 2006;39(9):879-87.
2006: Ntoulia Maria; Kaklamanis Loukas; Valavanis Christos; Kafousi Maria; Stathopoulos Efstathios; Arapantoni Petroula; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization.
Clinical biochemistry 2006;39(9):942-6.
2006: Stathopoulos G P; Syrigos K; Aravantinos G; Polyzos A; Papakotoulas P; Fountzilas G; Potamianou A; Ziras N; Boukovinas J; Varthalitis J; Androulakis N; Kotsakis A; Samonis G; Georgoulias V
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer.
British journal of cancer 2006;95(5):587-92.
2006: Xenidis Nikos; Perraki Maria; Kafousi Maria; Apostolaki Stella; Bolonaki Irene; Stathopoulou Aliki; Kalbakis Kostas; Androulakis Nikos; Kouroussis Charalambos; Pallis Thanos; Christophylakis Charalambos; Argyraki Katerina; Lianidou Evi S; Stathopoulos Stathis; Georgoulias Vassilis; Mavroudis Dimitris
Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3756-62.
2006: Hatzidaki Dora; Agelaki Sofia; Mavroudis Dimitris; Vlachonikolis Ioannis; Alegakis Athanasios; Georgoulias Vassilis;
A retrospective analysis of second-line chemotherapy or best supportive care in patients with advanced-stage non-small-cell lung cancer.
Clinical lung cancer 2006;8(1):49-55.
2006: Makrantonakis P; Ziotopoulos P; Agelidou A; Polyzos A; Ziras A; Chandrinos V; Vossos A; Kalykaki A; Androulakis N; Geroyianni A; Georgoulias V;
Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: a multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):85-90.
2006: Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Lung cancer (Amsterdam, Netherlands) 2006;53(1):59-65.
2006: Dimitrakopoulou-Strauss Antonia; Georgoulias Vassilios; Eisenhut Michael; Herth Felix; Koukouraki Sophia; Mäcke Helmut R; Haberkorn Uwe; Strauss Ludwig G
Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.
European journal of nuclear medicine and molecular imaging 2006;33(7):823-30.
2006: Pallis Athanasios G; Agelidou Athina; Papakotoulas Pavlos; Tsaroucha Aimilia; Agelidou Maria; Agelaki Sohia; Androulakis Nikolaos; Vamvakas Lambros; Gerogianni Athina; Kotsakis Athanasios; Kentepozidis Nikolaos; Georgoulias Vassilis
A multicenter phase II study of sequential vinorelbine and cisplatin followed by docetaxel and gemcitabine in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;52(2):165-71.
2006: Koukouraki Sophia; Strauss Ludwig G; Georgoulias Vassilios; Schuhmacher Jochen; Haberkorn Uwe; Karkavitsas Nikolaos; Dimitrakopoulou-Strauss Antonia
Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
European journal of nuclear medicine and molecular imaging 2006;33(4):460-6.
2006: Souglakos J; Androulakis N; Syrigos K; Polyzos A; Ziras N; Athanasiadis A; Kakolyris S; Tsousis S; Kouroussis Ch; Vamvakas L; Kalykaki A; Samonis G; Mavroudis D; Georgoulias V
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).
British journal of cancer 2006;94(6):798-805.
2006: Karampeazis A; Vamvakas L; Agelaki S; Kentepozidis N; Papadimitraki E; Gioulbasanis I; Vardakis N; Ignatiadis M; Mavroudis D; Georgoulias V
A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
Oncology 2006;71(5-6):347-53.
2006: Ignatiadis Michail; Polyzos Aris; Stathopoulos George P; Tselepatiotis Evangelos; Christophylakis Charalambos; Kalbakis Kostas; Vamvakas Lambros; Kotsakis Athanasios; Potamianou Anna; Georgoulias Vassilis
A multicenter phase II study of docetaxel in combination with gefitinib in gemcitabine-pretreated patients with advanced/metastatic pancreatic cancer.
Oncology 2006;71(3-4):159-63.
2006: Kalykaki A; Vamvakas L; Agelaki S; Kalbakis K; Vardakis N; Sfakiotaki G; Ignatiadis M; Saridaki Z; Karampeazis A; Mavroudis D; Georgoulias V
A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors.
Oncology 2006;71(3-4):197-203.
2006: Kotsakis A; Kouroussis Ch; Androulakis N; Agelaki S; Kalbakis K; Vamvakas L; Vardakis N; Kalykaki A; Polyzos A; Georgoulias V; Mavroudis D
A dose-escalation study of pegylated liposomal Doxorubicin and oxaliplatin in patients with advanced solid tumors.
Oncology 2006;71(3-4):190-6.
2006: Mavroudis D; Bolonakis I; Cornet S; Myllaki G; Kanellou P; Kotsakis A; Galanis A; Nikoloudi I; Spyropoulou M; Menez J; Miconnet I; Niniraki M; Cordopatis P; Kosmatopoulos K; Georgoulias V
A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignancies.
Oncology 2006;70(4):306-14.
2006: Androulakis Nikolaos; Aravantinos Gerasimos; Syrigos Kostas; Polyzos Aris; Ziras Nikolaos; Tselepatiotis Evangelos; Samonis George; Kentepozidis Nikolaos; Giassas Stylianos; Vamvakas Lambros; Georgoulias Vassilis
Oxaliplatin as first-line treatment in inoperable biliary tract carcinoma: a multicenter phase II study.
Oncology 2006;70(4):280-4.
2006: Kakolyris S; Kalbakis K; Potamianou A; Malamos N; Vamvakas L; Christophillakis C; Tselepatiotis E; Giassas S; Mavroudis D; Amarantidis K; Georgoulias V
Salvage chemotherapy with gemcitabine and oxaliplatin in heavily pretreated patients with metastatic breast cancer: a multicenter phase II study.
Oncology 2006;70(4):273-9.
2006: Souglakos John; Vamvakas Lambros; Apostolaki Stella; Perraki Maria; Saridaki Zacharenia; Kazakou Irine; Pallis Athanasios; Kouroussis Charalambos; Androulakis Nikos; Kalbakis Kostas; Millaki Georgia; Mavroudis Dimitris; Georgoulias Vassilis
Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu status.
Breast cancer research : BCR 2006;8(4):R36.
2006: Ziras N; Potamianou A; Varthalitis I; Syrigos K; Tsousis S; Boukovinas I; Tselepatiotis E; Christofillakis C; Georgoulias V
Multicenter phase II study of gemcitabine and oxaliplatin (GEMOX) as second-line chemotherapy in colorectal cancer patients pretreated with 5-fluorouracil plus irinotecan.
Oncology 2006;70(2):106-14.
2005: Michalakis John; Georgatos Spyros D; Romanos John; Koutala Helen; Georgoulias Vassilis; Tsiftsis Dimitris; Theodoropoulos Panayiotis A
Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells.
Cancer chemotherapy and pharmacology 2005;56(6):615-22.
2005: Ignatiadis Michail; Mavroudis Dimitris; Veslemes Marinos; Boukovinas John; Syrigos Kostas; Agelidou Maria; Agelidou Athina; Gerogianni Aleka; Pavlakou Georgia; Tselepatiotis Evaggelos; Nikolakopoulos John; Georgoulias Vassilis
Sequential versus alternating administration of cisplatin/etoposide and topotecan as first-line treatment in extensive-stage small-cell lung cancer: preliminary results of a Phase III Trial of the Hellenic Oncology Research Group.
Clinical lung cancer 2005;7(3):183-9.
2005: Chalkiadakis G E; Lasithiotakis K G; Petrakis I; Kourousis C; Georgoulias V
Major hepatectomy and right hemicolectomy at the time of primary cytoreductive surgery for advanced ovarian cancer: report of a case.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2005;15(6):1115-9.
2005: Agelaki Sofia; Georgoulias Vassilis
Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer.
Expert opinion on emerging drugs 2005;10(4):855-74.
2005: Georgoulias V; Agelidou A; Syrigos K; Rapti A; Agelidou M; Nikolakopoulos J; Polyzos A; Athanasiadis A; Tselepatiotis E; Androulakis N; Kalbakis K; Samonis G; Mavroudis D
Second-line treatment with irinotecan plus cisplatin vs cisplatin of patients with advanced non-small-cell lung cancer pretreated with taxanes and gemcitabine: a multicenter randomised phase II study.
British journal of cancer 2005;93(7):763-9.
2005: Ziotopoulos Panagiotis; Androulakis Nikolaos; Mylonaki Efthimia; Chandrinos Vassilios; Zachariadis Emmanouel; Boukovinas Ioannis; Agelidou Athina; Kentepozidis Nikolaos; Ignatiadis Michail; Vossos Andreas; Georgoulias Vassilis;
Front-line treatment of advanced non-small cell lung cancer with irinotecan and docetaxel: a multicentre phase II study.
Lung cancer (Amsterdam, Netherlands) 2005;50(1):115-22.
2005: Polyzos Aristides; Kosmas Christos; Toufexi Helen; Malamos Nicholas; Lagadas Antonios; Kosmidis Christos; Ginopoulos Panagiotis; Ziras Nicholas; Kandilis Kostas; Georgoulias Vassilis
Docetaxel in combination with irinotecan (CPT-11) in platinum-resistant paclitaxel-pretreated ovarian cancer.
Anticancer research 2005;25(5):3559-64.
2005: Rapti Ageliki; Agelidou Athina; Stergiou Ioannis; Agelidou Maria; Nikolakopoulos Ioannis; Varthalitis John; Kalykaki Antonia; Chainis Kyriakos; Tzanakis Nikolaos; Georgoulias Vassilis;
Combination of vinorelbine plus gemcitabine in previously treated patients with small cell lung cancer: a multicentre phase II study.
Lung cancer (Amsterdam, Netherlands) 2005;49(2):241-4.
2005: Aravantinos G; Fountzilas G; Kosmidis P; Dimopoulos M A; Stathopoulos G P; Pavlidis N; Bafaloukos D; Papadimitriou C; Karpathios S; Georgoulias V; Papakostas P; Kalofonos H P; Grimani E; Skarlos D V;
Paclitaxel plus carboplatin versus paclitaxel plus alternating carboplatin and cisplatin for initial treatment of advanced ovarian cancer: long-term efficacy results: a Hellenic Cooperative Oncology Group (HeCOG) study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1116-22.
2005: Twelves Chris; Wong Alfred; Nowacki Marek P; Abt Markus; Burris Howard; Carrato Alfredo; Cassidy Jim; Cervantes Andrés; Fagerberg Jan; Georgoulias Vassilis; Husseini Fares; Jodrell Duncan; Koralewski Piotr; Kröning Hendrik; Maroun Jean; Marschner Norbert; McKendrick Joseph; Pawlicki Marek; Rosso Riccardo; Schüller Johannes; Seitz Jean-François; Stabuc Borut; Tujakowski Jerzy; Van Hazel Guy; Zaluski Jerzy; Scheithauer Werner
Capecitabine as adjuvant treatment for stage III colon cancer.
The New England journal of medicine 2005;352(26):2696-704.
2005: Georgoulias Vassilis; Ardavanis Alexandros; Tsiafaki Xanthi; Agelidou Athina; Mixalopoulou Penelope; Anagnostopoulou Ourania; Ziotopoulos Panagiotis; Toubis Michael; Syrigos Kostas; Samaras Nikolaos; Polyzos Aris; Christou Anna; Kakolyris Stylianos; Kouroussis Charalambos; Androulakis Nikolaos; Samonis George; Chatzidaki Dora
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2937-45.
2005: Polyzos Aristides; Syrigos Konstantinos; Stergiou John; Panopoulos Christos; Potamianou Anna; Vamvakas Lambros; Georgoulias Vassilios
Phase I trial of weekly docetaxel with a 4-weekly cisplatin administration in patients with advanced gastric carcinoma.
Cancer chemotherapy and pharmacology 2005;55(5):466-70.
2005: Androulakis Nikos; Georgoulias Vassilis
NSCLC--platinum or not.
Lung cancer (Amsterdam, Netherlands) 2005;47(3):381-3.
2005: Stathopoulos E N; Sanidas E; Kafousi M; Mavroudis D; Askoxylakis J; Bozionelou V; Perraki M; Tsiftsis D; Georgoulias V
Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):240-6.
2005: Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kouroussis Ch; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2005;10(1):47-52.
2005: Souglakos J; Pallis A; Kakolyris S; Mavroudis D; Androulakis N; Kouroussis C; Agelaki S; Xenidis N; Milaki G; Georgoulias V
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.
Oncology 2005;69(5):384-90.
2005: Potamianou Anna; Androulakis Nikolaos; Papakotoulas Pavlos; Toufexi Helen; Latoufis Christos; Kouroussis Charalambos; Christofilakis Charalambos; Xenidis Nikolaos; Georgoulias Vassilios; Polyzos Aristidis
Sequential combination of paclitaxel-carboplatin and paclitaxel-liposomal doxorubicin as a first-line treatment in patients with ovarian cancer. A multicenter phase II trial.
Oncology 2005;69(4):348-53.
2005: Souglakos John; Kakolyris Stylianos; Vardakis Nikolaos; Androulakis Nikolaos; Mavroudis Dimitrios; Vamvakas Lambos; Kouroussis Charalambos; Agelaki Sophia; Saridaki Zacharenia; Georgoulias Vassilis
A dose escalating study of oxaliplatin and high dose weekly leucovorin and 5-Fluorouracil in patients with advanced solid tumors.
Cancer investigation 2005;23(6):505-10.
2005: Kouroussis Ch; Androulakis N; Vamvakas L; Kalykaki A; Spiridonakou S; Kentepozidis N; Saridaki Z; Xiropoulou El; Georgoulias V
Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumors.
Oncology 2005;69(3):202-7.
2005: Lionis Christos; Samoutis George; Kouroussis Charalambos; Trigoni Maria; Georgoulias Vassilios
Teaching cancer management to primary care health staff: the first experiences gained from Crete.
Journal of cancer education : the official journal of the American Association for Cancer Education 2005;20(1):6-7.
2004: Bozionellou Vassiliki; Mavroudis Dimitris; Perraki Maria; Papadopoulos Savvas; Apostolaki Stella; Stathopoulos Efstathios; Stathopoulou Aliki; Lianidou Evi; Georgoulias Vassilis
Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(24):8185-94.
2004: Kouroussis Charalambos; Kalbakis Konstantinos; Androulakis Nikolaos; Agelaki Sophia; Vamvakas Lambros; Malas Konstantinos; Souglakos John; Vardakis Nikolaos; Georgoulias Vassilis
A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.
Anticancer research 2004;24(6):4217-21.
2004: Souglakos J; Syrigos K; Potamianou A; Polyzos A; Boukovinas I; Androulakis N; Kouroussis Ch; Vardakis N; Christophilakis Ch; Kotsakis A; Georgoulias V
Combination of irinotecan (CPT-11) plus oxaliplatin (L-OHP) as first-line treatment in locally advanced or metastatic gastric cancer: a multicentre phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1204-9.
2004: Georgoulias V; Kouroussis C; Agelidou A; Boukovinas I; Palamidas P; Stavrinidis E; Polyzos A; Syrigos K; Veslemes M; Toubis M; Ardavanis A; Tselepatiotis E; Vlachonikolis I;
Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.
British journal of cancer 2004;91(3):482-8.
2004: Georgoulias Vassilis; Ardavanis Alexandros; Agelidou Athina; Agelidou Maria; Chandrinos Vassilis; Tsaroucha Emilia; Toumbis Michael; Kouroussis Charalambos; Syrigos Konstantinos; Polyzos Aristidis; Samaras Nikolaos; Papakotoulas Pavlos; Christofilakis Charalambos; Ziras Nicolaos; Alegakis Athanasios
Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2602-9.
2004: Kouroussis Charalambos; Mavroudis Dimitris; Kakolyris Stylianos; Voloudaki Argyro; Kalbakis Konstantinos; Souglakos John; Agelaki Sophia; Malas Konstantinos; Bozionelou Vassiliki; Georgoulias Vassilis
High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study.
Lung cancer (Amsterdam, Netherlands) 2004;44(3):363-8.
2004: Anatoliotaki M; Valatas V; Mantadakis E; Apostolakou H; Mavroudis D; Georgoulias V; Rolston K V; Kontoyiannis D P; Galanakis E; Samonis G
Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome.
Infection 2004;32(2):65-71.
2004: Agelaki Sofia; Veslemes Marinos; Syrigos Kostas; Palamidas Filippos; Polyzos Aristidis; Papakotoulas Pavlos; Kentepozidis Nikolaos; Milaki Georgia; Tzanakis Nikolaos; Kouroussis Charalambos; Vamvakas Lambros; Georgoulias Vassilis;
A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2004;43(3):329-33.
2004: Stathopoulos G P; Syrigos K; Polyzos A; Fountzilas G; Rigatos S K; Ziras N; Potamiannou A; Tsiakopoulos I; Androulakis N; Aravantinos G; Athanasiadis A; Papakotoulas P; Georgoulias V
Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):224-9.
2004: Fountzilas George; Stathopoulos G; Kouvatseas G; Polychronis A; Klouvas G; Samantas E; Zamboglou N; Kyriakou K; Adamou A; Pectasidis D; Ekonomopoulos Th; Kalofonos H P; Bafaloukos D; Georgoulias V; Razis E; Koukouras D; Zombolas V; Kosmidis P; Skarlos D; Pavlidis N;
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
American journal of clinical oncology 2004;27(1):57-67.
2004: Giatromanolaki Alexandra; Koukourakis Michael I; Kakolyris Stelios; Mavroudis Dimitris; Kouroussis Charalambos; Mavroudi Chrysa; Perraki Maria; Sivridis Efthimios; Georgoulias Vassilis
Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse.
International journal of cancer. Journal international du cancer 2004;108(4):620-7.
2004: Mavroudis D; Malamos N; Polyzos A; Kouroussis Ch; Christophilakis Ch; Varthalitis I; Androulakis N; Kalbakis K; Milaki G; Georgoulias V;
Front-line chemotherapy with docetaxel and gemcitabine administered every two weeks in patients with metastatic breast cancer: a multicenter phase II study.
Oncology 2004;67(3-4):250-6.
2004: Agelaki Sofia; Syrigos Kostas; Christophylakis Charalambos; Boukovinas John; Varthalitis John; Pavlakou Georgia; Athanasiadis Athanasios; Kouroussis Charalambos; Vardakis Nikolaos; Maltezakis George; Milaki Georgia; Georgoulias Vassilis;
A multicenter phase II study of the combination of irinotecan and gemcitabine in previously treated patients with small-cell lung cancer.
Oncology 2004;66(3):192-6.
2004: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Samonis G; Vardakis N; Amarantidis K; Agelaki S; Mavroudis D; Xenidis N; Georgoulias V
Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.
Oncology 2004;66(4):253-9.
2003: Samonis George; Maraki Sofia; Kouroussis Charalambos; Mavroudis Dimitrios; Georgoulias Vassilios
Salmonella enterica pneumonia in a patient with lung cancer.
Journal of clinical microbiology 2003;41(12):5820-2.
2003: Angelopoulou Katerina; Spiropoulou Tonia; Stathopoulou Aliki; Dimitroulopoulos Dimitris; Malamos Nikos; Georgoulias Vassilis; Paraskevas Emanouil; Lianidou Evi S
Development of a highly sensitive RT-PCR luminometric hybridization assay for human telomerase reverse-transcriptase beta-plus transcript.
Anticancer research 2003;23(6C):4821-9.
2003: Stathopoulou Aliki; Gizi Anna; Perraki Maria; Apostolaki Stella; Malamos Nikos; Mavroudis Dimitris; Georgoulias Vassilis; Lianidou Evi S
Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5145-51.
2003: Souglakos John; Androulakis Nikolaos; Mavroudis Dimitrios; Kourousis Charalabos; Kakolyris Stylianos; Vardakis Nikolaos; Kalbakis Konstantinos; Pallis Athanasios; Ardavanis Alexandros; Varveris Charalabos; Georgoulias Vassilios
Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer.
International journal of radiation oncology, biology, physics 2003;56(5):1284-7.
2003: Fountzilas George; Razis Evangelia; Tsavdaridis Dimitrios; Karina Maria; Labropoulos Stefanos; Christodoulou Christos; Mavroudis Dimitrios; Gogas Helen; Georgoulias Vassilios; Skarlos Dimosthenis
Continuation of trastuzumab beyond disease progression is feasible and safe in patients with metastatic breast cancer: a retrospective analysis of 80 cases by the hellenic cooperative oncology group.
Clinical breast cancer 2003;4(2):120-5.
2003: Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(6):849-55.
2003: Pallis A G; Mavroudis D; Androulakis N; Souglakos J; Kouroussis C; Bozionelou V; Vlachonikolis I G; Georgoulias V
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program.
Lung cancer (Amsterdam, Netherlands) 2003;40(3):301-7.
2003: Georgoulias V; Pallis A G; Kourousis C; Alexopoulos A; Ardavanis A; Agelidou A; Agelidou M; Toumbis M; Tzannes S; Pavlakou G; Ziotopoulos P; Tzelepatiotis E; Samaras N
Docetaxel versus docetaxel/cisplatin in patients with advanced non-small-cell lung cancer: preliminary analysis of a multicenter, randomized phase III study.
Clinical lung cancer 2003;4(5):288-93.
2003: Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Anticancer research 2003;23(2C):1883-90.
2003: Stathopoulos G P; Rigatos S K; Dimopoulos M A; Giannakakis T; Foutzilas G; Kouroussis C; Janninis D; Aravantinos G; Androulakis N; Agelaki S; Stathopoulos J G; Georgoulias V;
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):388-94.
2003: Mavroudis D; Pappas P; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Nikolaidou M; Samonis G; Marselos M; Georgoulias V
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(2):304-12.
2003: Kouroussis Charalambos; Agelaki Sophia; Mavroudis Dimitris; Kakolyris Stylianos; Androulakis Nick; Kalbakis Kostas; Souglakos John; Mallas Kostas; Bozionelou Vassiliki; Pallis Athanasios; Adamtziki Helen; Georgoulias Vassilis
A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
Anticancer research 2003;23(1B):785-91.
2003: Mavroudis D; Pavlakou G; Blazoyiannakis G; Veslemes M; Apostolopoulou F; Kouroussis Ch; Kakolyris S; Agelaki S; Androulakis N; Vardakis N; Magkanas E; Samonis G; Georgoulias V
Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2003;39(1):71-6.
2003: Agelaki S; Karyda E; Kouroussis Ch; Ardavanis A; Kalbakis K; Malas K; Malamos N; Alexopoulos A; Tselepatiotis E; Georgoulias V
Gemcitabine plus irinotecan in breast cancer patients pretreated with taxanes and anthracyclines: a multicenter phase II study.
Oncology 2003;64(4):477-8.
2003: Mavroudis D; Alexopoulos A; Malamos N; Ardavanis A; Kandylis C; Stavrinidis E; Kouroussis Ch; Agelaki S; Androulakis N; Bozionelou V; Georgoulias V
Salvage treatment of metastatic breast cancer with docetaxel and carboplatin. A multicenter phase II trial.
Oncology 2003;64(3):207-12.
2002: Kouroussis Charalambos; Souglakos John; Mavroudis Dimitris; Papadouris Savvakis; Kakolyris Stylianos; Agelaki Sophia; Kalbakis Kostas; Panopoulos Christos; Vardakis Nikos; Sarra Evanthia; Georgoulias Vassilis
Oxaliplatin with high-dose leucovorin and infusional 5-fluorouracil in irinotecan-pretreated patients with advanced colorectal cancer (ACC).
American journal of clinical oncology 2002;25(6):627-31.
2002: Giannakakis Theodore; Kakolyris Stelios; Theodoropoulos Elias; Kouroussis Charalambos; Michailakis Emmanuel; Papadouris Savvakis; Tsitoura Miranda; Kalbakis Kostas; Souglakos John; Agelaki Sohia; Vardakis Nikos; Georgoulias Vassilis
A multicenter phase II study of docetaxel and carboplatin combination as front-line treatment in advanced non-small cell lung cancer.
Anticancer research 2002;22(6B):3743-8.
2002: Androulakis N; Kouroussis C; Mavroudis D; Kakolyris S; Souglakos J; Agelaki S; Kalbakis K; Malas K; Pallis A; Samonis G; Georgoulias V
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours.
European journal of cancer (Oxford, England : 1990) 2002;38(15):1992-7.
2002: Mavroudis D; Veslemes M; Kouroussis Ch; Tzanakis N; Ferdoutsis E; Toumbis M; Ziotopoulos P; Agelidou M; Tselepatiotis E; Kalbakis K; Souglakos J; Magkanas E; Samonis G; Georgoulias V;
Cisplatin-etoposide alternating with topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2002;38(1):59-63.
2002: Souglakos John; Kotsakis Athanaslos; Kouroussis Charalambos; Kakolyris Stylianos; Mavroudis Dimitrios; Kalbakis Konstadinos; Agelaki Sofia; Vlachonikolis John; Georgoulias Vassilis; Samonis George
Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors.
Cancer 2002;95(6):1326-33.
2002: Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3404-12.
2002: Souglakos J; Mavroudis D; Kakolyris S; Kourousis Ch; Vardakis N; Androulakis N; Agelaki S; Kalbakis K; Tsetis D; Athanasiadis N; Samonis G; Georgoulias V
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2651-7.
2002: Kakolyris Stylianos Souglakos John; Kouroussis Charalambos; Koukourakis Michael; Kalbakis Kostas; Mavroudis Dimitris; Vardakis Nick; Georgoulias Vassilis
A dose-escalation study of irinotecan (CPT-11) in combination with gemcitabine in patients with advanced non-small cell lung cancer previously treated with a cisplatin-based front line chemotherapy.
Anticancer research 2002;22(3):1891-6.
2002: Georgoulias Vassilis
Docetaxel (taxotere) in the treatment of non-small cell lung cancer.
Current medicinal chemistry 2002;9(8):869-77.
2002: Vamvakas L; Kakolyris S; Kouroussis C; Kandilis K; Mavroudis D; Ziras N; Androulakis N; Kalbakis K; Sarra E; Souglakos J; Georgoulias V;
Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study.
American journal of clinical oncology 2002;25(1):65-70.
2002: Koukourakis Michael I; Giatromanolaki Alexandra; Kouroussis Charalambos; Kakolyris Stelios; Sivridis Efthimios; Frangiadaki Chryssi; Retalis George; Georgoulias Vassilis;
Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.
International journal of radiation oncology, biology, physics 2002;52(1):144-55.
2002: Kakolyris S; Kouroussis C; Koukourakis M; Mavroudis D; Malas K; Vardakis N; Bozionelou V; Kalbakis K; Georgoulias V
A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.
Oncology 2002;63(3):213-8.
2002: Mavroudis D; Kouroussis Ch; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Samonis G; Georgoulias V
Phase I study of paclitaxel (taxol) and pegylated liposomal doxorubicin (caelyx) administered every 2 weeks in patients with advanced solid tumors.
Oncology 2002;62(3):216-22.
2002: Kosmas C; Agelaki S; Giannakakis Th; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
Oncology 2002;62(2):103-9.
2001: Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Kalbakis K; Rapti A; Androulakis N; Georgoulias V; Papadakis E
Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S77-80.
2001: Kakolyris S; Kouroussis C; Souglakos J; Agelaki S; Kalbakis K; Vardakis N; Vamvakas L; Georgoulias V
Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S71-6.
2001: Georgoulias V; Samonis G; Papadakis E; Alexopoulos A; Tsiafaki X; Rapti A; Veslemes M; Grigoratou T; Palamidas P; Kouroussis C; Mavroudis D; Kakolyris S; Giannakakis T; Vlachonikolis J;
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 4():S47-51.
2001: Kakolyris S; Giatromanolaki A; Koukourakis M; Kaklamanis L; Kouroussis C H; Bozionelou V; Georgoulias V; Gatter K C; Harris A L
Assessment of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39.
Anticancer research 2001;21(6B):4311-6.
2001: Stathopoulou A; Angelopoulou K; Perraki M; Georgoulias V; Malamos N; Lianidou E
Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer.
Clinical biochemistry 2001;34(8):651-9.
2001: Kakolyris S; Giatromanolaki A; Koukourakis M; Powis G; Souglakos J; Sivridis E; Georgoulias V; Gatter K C; Harris A L
Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3087-91.
2001: Papakostas P; Kouroussis C; Androulakis N; Samelis G; Aravantinos G; Kalbakis K; Sarra E; Souglakos J; Kakolyris S; Georgoulias V
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
European journal of cancer (Oxford, England : 1990) 2001;37(15):1833-8.
2001: Agelaki S; Kakolyris S; Palamidas P; Kouroussis C; Mavroudis D; Kalbakis K; Georgoulias V; Raptis A
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34(1):133-9.
2001: Kalbakis K; Kouroussis C; Kakolyris S; Mavroudis D; Souglakos J; Agelaki S; Vamvakas L; Christodoulakis M; Stylianou K; Georgoulias V
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
British journal of cancer 2001;85(6):798-802.
2001: Kouroussis C; Kakolyris S; Mavroudis D; Androulakis N; Kalbakis K; Agelaki S; Sarra E; Souglakos J; Christodoulakis M; Samonis G; Georgoulias V
A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors.
American journal of clinical oncology 2001;24(4):404-7.
2001: Alexopoulos A; Kouroussis C; Malamos N; Kakolyris S; Kalbakis K; Kosmas C; Mavroudis D; Agelaki S; Vlachonicolis J; Sarra E; Rigatos G; Georgoulias V
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(6):793-8.
2001: Janinis J; Papadakou M; Panagos G; Panousaki A; Georgoulias V; Hatzidaki D; Lefantzis D; Dokianakis G
Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer.
American journal of clinical oncology 2001;24(3):227-31.
2001: Samonis G; Anatoliotaki M; Apostolakou H; Maraki S; Mavroudis D; Georgoulias V
Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature.
Infection 2001;29(3):173-6.
2001: Georgoulias V; Papadakis E; Alexopoulos A; Tsiafaki X; Rapti A; Veslemes M; Palamidas P; Vlachonikolis I;
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial.
Lancet 2001;357(9267):1478-84.
2001: Kakolyris S; Papadakis E; Tsiafaki X; Kalofonos C; Rapti A; Toubis M; Bania E; Kouroussis C; Chainis K; Androulakis N; Agelaki S; Sarra E; Vardakis N; Georgoulias V;
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
Lung cancer (Amsterdam, Netherlands) 2001;32(2):179-87.
2001: Koukourakis M I; Giatromanolaki A; Kakolyris S; Sivridis E; Georgoulias V; Funtzilas G; Hickson I D; Gatter K C; Harris A L
Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.
International journal of radiation oncology, biology, physics 2001;50(1):27-36.
2001: Mavroudis D; Papadakis E; Veslemes M; Tsiafaki X; Stavrakakis J; Kouroussis C; Kakolyris S; Bania E; Jordanoglou J; Agelidou M; Vlachonicolis J; Georgoulias V;
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(4):463-70.
2001: Kakolyris S; Mavroudis D; Tsavaris N; Souglakos J; Tsiafaki P; Kalbakis K; Agelaki S; Androulakis N; Georgoulias V
Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(2):193-7.
2001: Georgoulias V A
Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer.
Oncology (Williston Park, N.Y.) 2001;15(2 Suppl 3):18-24.
2001: Stathopoulos G P; Mavroudis D; Tsavaris N; Kouroussis C; Aravantinos G; Agelaki S; Kakolyris S; Rigatos S K; Karabekios S; Georgoulias V
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):101-3.
2001: Kakolyris S; Kouroussis C; Souglakos J; Mavroudis D; Agelaki S; Kalbakis K; Androulakis N; Vardakis N; Vamvakas L; Georgoulias V
A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumors.
Oncology 2001;61(4):265-70.
2001: Samonis G; Anatoliotaki M; Apostolakou H; Souglakos J; Georgoulias V
Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease.
Scandinavian journal of infectious diseases 2001;33(7):553-5.
2001: Kouroussis C; Souglakos J; Kakolyris S; Mavroudis D; Malamos N; Kalbakis K; Androulakis N; Agelaki A; Vardakis N; Samonis G; Georgoulias V
Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: a phase II study.
Oncology 2001;61(1):36-41.
2001: Agelaki S; Bania H; Kouroussis C; Blazoyiannakis G; Souglakos J; Tsiafaki X; Harpidou A; Kalbakis K; Rapti A; Androulakis N; Sarra E; Georgoulias V; Papadakis E
Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials.
Oncology 2001;60(3):235-41.
2001: Kakolyris S; Souglakos J; Kouroussis C; Androulakis N; Mavroudis D; Kalbakis K; Kotsakis A; Vardakis N; Koukourakis M; Romanos J; Georgoulias V
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer.
Oncology 2001;60(3):207-13.
2000: Kakolyris S; Souglakos J; Agelaki S; Kourousis C H; Mavroudis D; Sarra E; Malliotakis P; Georgoulias V
A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy.
Lung cancer (Amsterdam, Netherlands) 2000;30(3):193-8.
2000: Mavroudis D; Alexopoulos A; Ziras N; Malamos N; Kouroussis C; Kakolyris S; Agelaki S; Kalbakis K; Tsavaris N; Potamianou A; Rigatos G; Georgoulias V
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(10):1249-54.
2000: Kotsakis A; Sarra E; Peraki M; Koukourakis M; Apostolaki S; Souglakos J; Mavromanomakis E; Vlachonikolis J; Georgoulias V
Docetaxel-induced lymphopenia in patients with solid tumors: a prospective phenotypic analysis.
Cancer 2000;89(6):1380-6.
2000: Kakolyris S; Georgoulias V
The role of gemcitabine and paclitaxel as second-line chemotherapy for the treatment of advanced non small-cell lung cancer (NSCLC).
Clinical lung cancer 2000;2(1):43-7.
2000: Mavroudis D; Kourousis C; Androulakis N; Kalbakis K; Agelaki S; Kakolyris S; Souglakos J; Sarra E; Vardakis N; Hatzidaki D; Sarmonis G; Georgoulias V
Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial.
American journal of clinical oncology 2000;23(4):341-4.
2000: Dimopoulos M A; Papadimitriou C A; Georgoulias V; Moulopoulos L A; Aravantinos G; Gika D; Karpathios S; Stamatelopoulos S
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study.
Gynecologic oncology 2000;78(1):52-7.
2000: Kakolyris S; Kouroussis C; Kalbakis K; Mavroudis D; Souglakos J; Nvardakis; Kremos S; Georgoulias V
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(6):757-60.
2000: Kouroussis C; Samonis G; Androulakis N; Souglakos J; Voloudaki A; Dimopoulos M A; Kotsakis T; Kakolyris S; Kalbakis K; Georgoulias V
Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases.
American journal of clinical oncology 2000;23(3):309-13.
2000: Koukourakis M I; Kyrias G; Kakolyris S; Kouroussis C; Frangiadaki C; Giatromanolaki A; Retalis G; Georgoulias V
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(11):2226-33.
2000: Koukourakis M I; Giatromanolaki A; Kakolyris S; Froudarakis M; Georgoulias V; Retalis G; Bahlitzanakis N
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer.
Medical oncology (Northwood, London, England) 2000;17(2):135-43.
2000: Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
Histology and histopathology 2000;15(2):445-53.
2000: Giannakakis T; Ziras N; Kakolyris S; Mavroudis D; Androulakis N; Agelaki S; Parashos M; Sarra E; Dimou T; Hatzidaki D; Vlachonikolis J; Georgoulias V
Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study.
European journal of cancer (Oxford, England : 1990) 2000;36(6):742-7.
2000: Mavroudis D; Kourousis C; Kakolyris S; Agelaki S; Kalbakis K; Androulakis N; Souglakos J; Vardakis N; Samonis G; Georgoulias V
Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: a preliminary report.
Seminars in oncology 2000;27(1 Suppl 2):25-30.
2000: Kakolyris S A; Kaklamanis L G; Koukourakis M J; Giatromanolaki A; Rousomoustakaki M; Souglakos J C; Reppa D K; Georgoulias V A; Gatter K C; Harris A L
Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence.
Oncology research 2000;12(4):203-8.
2000: Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2000;46(6):488-92.
1999: Kakolyris S; Kourousis C; Koukourakis M; Androulakis N; Vamvakas L; Agelaki S; Hatzidaki D; Samonis G; Tsiftsis D; Georgoulias V
First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin.
American journal of clinical oncology 1999;22(6):568-72.
1999: Dimopoulos M A; Bakoyannis C; Georgoulias V; Papadimitriou C; Moulopoulos L A; Deliveliotis C; Karayannis A; Varkarakis I; Aravantinos G; Zervas A; Pantazopoulos D; Fountzilas G; Bamias A; Kyriakakis Z; Anagnostopoulos A; Giannopoulos A; Kosmidis P
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: a multicenter phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1385-8.
1999: Georgoulias V; Crown J P
Increasing options in cancer therapy: current status and future prospects.
Anti-cancer drugs 1999;10 Suppl 1():S1-3.
1999: Kouroussis C; Georgoulias V; Souglakos J; Simvoulakis E; Karabekios S; Samonis G
Spontaneous spondylodiscitis caused by Klebsiella pneumoniae.
Infection 1999;27(6):368-9.
1999: Kakolyris S; Giatromanolaki A; Koukourakis M; Kaklamanis L; Kanavaros P; Hickson I D; Barzilay G; Georgoulias V; Gatter K C; Harris A L
Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC).
The Journal of pathology 1999;189(3):351-7.
1999: Giatromanolaki A; Stathopoulos G P; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter K C; Harris A L; Koukourakis M I
Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Cancer 1999;86(8):1421-30.
1999: Theodoropoulos P A; Polioudaki H; Kostaki O; Derdas S P; Georgoulias V; Dargemont C; Georgatos S D
Taxol affects nuclear lamina and pore complex organization and inhibits import of karyophilic proteins into the cell nucleus.
Cancer research 1999;59(18):4625-33.
1999: Koukourakis M I; Bahlitzanakis N; Froudarakis M; Giatromanolaki A; Georgoulias V; Koumiotaki S; Christodoulou M; Kyrias G; Skarlatos J; Kostantelos J; Beroukas K
Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma.
British journal of cancer 1999;80(11):1792-6.
1999: Androulakis N; Kourousis C; Dimopoulos M A; Samelis G; Kakolyris S; Tsavaris N; Genatas K; Aravantinos G; Papadimitriou C; Karabekios S; Stathopoulos G P; Georgoulias V
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(6):1779-85.
1999: Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis J; Kalbakis K; Agelaki S; Chalkiadakis G; Sanidas E; Tsiftsis D; Georgoulias V
First-line treatment with mitoxantrone, methotrexate, vincristine, and carboplatine (MIMOC) plus cyclical hormonotherapy with tamoxifen and megestrol acetate in advanced breast cancer.
American journal of clinical oncology 1999;22(3):273-7.
1999: Kouroussis C; Xydakis E; Potamianou A; Giannakakis T; Kakolyris S; Agelaki S; Sara E; Malamos N; Alexopoulos A; Mavroudis D; Samonis G; Papadouris S; Georgoulias V; Panagos G
Front-line treatment of metastatic breast cancer with docetaxel and epirubicin: a multicenter dose-escalation study. The Greek Breast Cancer Cooperative Group (GBCCG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(5):547-52.
1999: Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V
Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
Medical oncology (Northwood, London, England) 1999;16(1):23-30.
1999: Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland M L; Gorgoulis V; Kittas C
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Anticancer research 1999;19(2A):1209-16.
1999: Georgoulias V; Kouroussis C; Androulakis N; Kakolyris S; Dimopoulos M A; Papadakis E; Bouros D; Apostolopoulou F; Papadimitriou C; Agelidou A; Hatzakis K; Kalbakis K; Kotsakis A; Vardakis N; Vlachonicolis J
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):914-20.
1999: Kouroussis C; Androulakis N; Kakolyris S; Souglakos J; Kotsakis T; Mavroudis D; Katsogridakis K; Vardakis N; Hatzidaki D; Samonis G; Vlachonikolis J; Georgoulias V
Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):862-9.
1999: Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(2):211-5.
1999: Sara E; Kotsakis A; Souklakos J; Kourousis C; Kakolyris S; Mavromanolakis E; Vlachonicolis J; Georgoulias V
Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4+ cell proliferation.
Anticancer research 1999;19(1A):471-6.
1999: Koukourakis M I; Giatromanolaki A; Schiza S; Kakolyris S; Georgoulias V
Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
International journal of radiation oncology, biology, physics 1999;43(1):107-14.
1999: Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Clinical and experimental pathology 1999;47(5):231-8.
1999: Giatromanolaki A; Sivridis E; Koukourakis M I; Georgoulias V; Gatter K C; Harris A L
Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?
Oncology research 1999;11(4):205-12.
1999: Alexopoulos K; Kouroussis C; Androulakis N; Papadakis E; Vaslamatzis M; Kakolyris S; Samelis G; Patila E; Vossos A; Samantas E; Georgoulias V
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
Cancer chemotherapy and pharmacology 1999;43(3):257-62.
1998: Kakolyris S; Kaklamanis L; Giatromanolaki A; Koukourakis M; Hickson I D; Barzilay G; Turley H; Leek R D; Kanavaros P; Georgoulias V; Gatter K C; Harris A L
Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein: a basis for its role in human disease.
Histopathology 1998;33(6):561-9.
1998: Giatromanolaki A; Koukourakis M I; Kakolyris S; Turley H; O'Byrne K; Scott P A; Pezzella F; Georgoulias V; Harris A L; Gatter K C
Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3017-24.
1998: Koukourakis M I; Stefanaki I; Giatromanolaki A; Frangiadaki C; Armenaki A; Georgoulias V; Koumandakis E; Kranidis A; Helidonis E
Fractionated carboplatin radiosensitization: a phase I dose-escalation study.
American journal of clinical oncology 1998;21(6):595-601.
1998: Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
Cancer 1998;83(10):2083-90.
1998: Androulakis N; Kouroussis C; Kakolyris S; Tzannes S; Papadakis E; Papadimitriou C; Geroyianni A; Georgopoulou T; Dimopoulou I; Souglakos J; Kotsakis A; Vardakis N; Hatzidaki D; Georgoulias V
Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(10):1127-30.
1998: Kakolyris S; Samonis G; Koukourakis M; Vlachonicolis I; Chalkiadakis G; Kalbakis K; Souglakos I; Agelaki S; Toloudis P; Georgoulias V
Treatment of non-small-cell lung cancer with prolonged oral etoposide.
American journal of clinical oncology 1998;21(5):505-8.
1998: Georgoulias V; Androulakis N; Bouros D; Kouroussis C; Chatzakis K; Papadakis M; Apostopoloulou F; Georgopoulou T; Kotsakis T; Souklakos J; Hatzidaki D; Vlachonikolis J; Panagos G
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.
Lung cancer (Amsterdam, Netherlands) 1998;21(3):213-20.
1998: Samonis G; Skordilis P; Maraki S; Datseris G; Toloudis P; Chatzinikolaou I; Georgoulias V; Bodey G P
Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(2):283-6.
1998: Stefanaki K; Tzardi M; Kouvidou C; Chaniotis V; Bolioti M; Vlychou M; Zois M; Kakolyris S; Delides G; Rontogianni D; Georgoulias V; Kanavaros P
Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid (MALT) tissue.
Anticancer research 1998;18(4A):2403-8.
1998: Kourousis C; Kakolyris S; Androulakis N; Heras P; Vlachonicolis J; Vamvakas L; Vlata M; Hatzidaki D; Samonis G; Georgoulias V
Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancer.
American journal of clinical oncology 1998;21(3):226-32.
1998: Koukourakis M I; Kourousis C; Kamilaki M; Koukouraki S; Giatromanolaki A; Kakolyris S; Kotsakis A; Androulakis N; Bahlitzanakis N; Georgoulias V
Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.
European journal of cancer (Oxford, England : 1990) 1998;34(6):838-44.
1998: Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Anticancer research 1998;18(3A):1689-95.
1998: Stefanaki K; Rontogiannis D; Vamvouka C; Bolioti S; Chaniotis V; Sotsiou F; Vlychou M; Delidis G; Kakolyris S; Georgoulias V; Kanavaros P
Immunohistochemical detection of bcl2, p53, mdm2 and p21/waf1 proteins in small-cell lung carcinomas.
Anticancer research 1998;18(2A):1167-73.
1998: Georgoulias V; Androulakis N; Dimopoulos A M; Kourousis C; Kakolyris S; Papadakis E; Apostolopoulou F; Papadimitriou C; Vossos A; Agelidou M; Heras P; Tzannes S; Vlachonicolis J; Mavromanolakis E; Hatzidaki D
First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin: a multicenter phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(3):331-4.
1997: Samonis G; Bafaloukos D; Margioris A N; Katsarma G; Toloudis P; Bacoyannis C; Karvounis N; Georgoulias V; Kosmidis P
First-line chemotherapy of advanced breast cancer with a combination of mitoxantrone, methotrexate, and vincristine (MIMO).
Oncology 1997;54(5):371-5.
1997: Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Dimopoulos M A; Bouros D; Papadimitriou C; Hatzakis K; Heras P; Kalbakis K; Kotsakis T; Vardakis N; Meramveliotakis N; Hatzidaki D
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.
Seminars in oncology 1997;24(4 Suppl 14):S14-22-S14-25.
1997: Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
Seminars in oncology 1997;24(4 Suppl 14):S14-9-S14-14.
1997: Georgoulias V; Kourousis C; Kakolyris S; Androulakis N; Dimopoulos M A; Papadakis E; Kotsakis T; Vardakis N; Kalbakis K; Merambeliotakis N; Hatzidaki D
Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: a preliminary report on an active regimen.
Seminars in oncology 1997;24(4 Suppl 12):S12-61-S12-66.
1997: Kouvidou C; Stefanaki K; Dai Y; Tzardi M; Koutsoubi K; Darivianaki K; Karidi E; Rontogianni D; Zois E; Kakolyris S; Georgoulias V; Delides G; Kanavaros P
P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression.
Anticancer research 1997;17(4A):2615-9.
1997: Valassiadou K E; Stefanaki K; Tzardi M; Datseris G; Georgoulias V; Melissas J; Tsiftsis D D; Delides G; Kanavaros P
Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas.
Anticancer research 1997;17(4A):2571-6.
1997: Koukourakis M I; Koukouraki S; Giatromanolaki A; Skarlatos J; Georgoulias V; Karkavitsas N
Non-small cell lung cancer functional imaging: increased hexakis-2-methoxy-isobutyl-isonitrile tumor clearance correlates with resistance to cytotoxic treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):749-54.
1997: Giannikaki E; Kouvidou C; Tzardi M; Stefanaki K; Koutsoubi K; Gregoriou M; Zois E; Kakolyris S; Mavroudi C; Delides G; Georgoulias V; Kanavaros P
p53 protein expression in breast carcinomas. Comparative study with the wild type p53 induced proteins mdm2 and p21/waf1.
Anticancer research 1997;17(3C):2123-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Vassilis Georgoulias

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Vassilis Georgoulias (preview)

All Publications